Chitosan / poly(vinyl alcohol) (PVA) |
Fe3O4
|
ES |
Bone regeneration |
MG63 human osteoblast–like cells |
[83] |
Hydroxyapatite (HA) nanoparticles and poly(lactic acid) (PLA) |
Super-paramagnetic Fe2O3 nanoparticles |
ES |
Bone tissue formation and remodeling in rabbit defects |
White rabbit model of lumbar transverse defects |
[32] |
Poly(ε-caprolactone) (PCL) |
MNPs |
ES |
Bone regeneration |
Osteoblastic cells and subcutaneously implanted in rats |
[73] |
Hydroxyapatite (HA) |
MNPs |
Immersion of MNPs into HA scaffold |
Bone repair |
ROS 17/2.8 and MC3T3-E1 cells |
[84] |
Magnetic poly(l-lactic acid) (PLLA) |
Fe3O4
|
ES |
Enhanced effects on cell attachment and proliferation |
MC3T3-E1 |
[85] |
Poly(d,l-lactic acid) (PDLLA) |
Superpara-magnetic iron oxide nanoparticles (SPIONs) |
ES |
Cell proliferation and induction of the cell orientation |
Osteoblast cells |
[86] |
Chitosan |
E-CHS-Fe3O4
|
ES |
Hyperthermia treatment of tumor cells |
HFL1 and caco-2 cells |
[87] |
Cross-linked chitosan |
Fe3O4
|
ES by iminodiacetic acid (IDA) |
Reduction of tumor cell proliferation |
Tumor cells |
[88] |
Polystyrene (PS) and poly(styrene-co-maleic anhydride) (PSMA) |
Magnetic NP-nanofibers (NF) |
ES with surface-embedded T cell receptor ligand |
Isolation and activation of primary CD3+ T lymphocytes |
Lymph nodes harvested from C57BL/6 mice |
[89] |
Porous hydroxyapatite composite |
Up-conversion of luminescent and MNPs |
ES |
Indomethacin, T1 magnetic resonance imaging (MRI) contrast agents, and luminescent nanoparticles |
MC 3T3-E1 cells |
[90] |
Hydroxyapatite nanocrystals within PCL |
Doped with gadolinium (Gd) |
ES |
In situ monitoring of bone tissue regeneration by MR |
Human mesenchymal stem cells |
[91] |
Amphiphilic peptide |
Macrocyclic Gd (III) |
β-sheet amino acid sequence |
MRI |
Tibialis anterior muscle of a murine model |
[92] |